Characteristics | N | Unsuccessful treatment outcomes (n %) | COR (95% CI) | AOR (95% CI) |
Sex |
|
|
|
|
Male | 5057 | 324(6.4) | 1.37 (1.15, 1.63)* | 1.27 (0.98, 1.64) |
Female | 4970 | 236 (4.7) | 1 | 1 |
Age group |
|
|
|
|
0 - 14 | 1094 | 36 (3.3) | 0.33 (0.23, 0.49)* | 0.20 (0.10, 0.40)** |
15 - 24 | 2873 | 111 (3.9) | 0.39 (0.29, 0.51)* | 0.36 (0.25, 0.53)** |
25 - 49 | 4683 | 286 (6.1) | 0.63 (0.51, 0.79)* | 0.45 (0.33, 0.63)** |
≥50 | 1444 | 133 (9.2) | 1 | 1 |
Residence |
|
|
|
|
Urban | 3080 | 218 (7.1) | 1.46 (1.22, 1.74)* | 0.835 (0.64, 1.09) |
Rural | 6240 | 310 (5.0) | 1 | 1 |
Type of TB |
|
|
|
|
PTB− | 2885 | 222 (7.7) | 0.99 (0.81, 1.23) | 1.18 (0.84, 1.65) |
EPTB | 5087 | 182 (3.6) | 0.44 (0.36, 0.55)* | 0.57 (0.40, 0.82)** |
PTB+ | 2084 | 161 (7.7) | 1 | 1 |
Category |
|
|
|
|
Retreatment | 146 | 23 (15.7) | 3.25 (2.06, 5.11)* | 3.44 (1.92, 6.19)** |
New | 9242 | 503 (5.4) | 1 | 1 |
HIV sero-status |
|
|
|
|
Reactive | 589 | 82 (13.9) | 3.42 (2.61, 4.48)* | 2.68 (1.92, 3.72)** |
Non-reactive | 4732 | 214 (4.5) | 1 | 1 |